The alab buy hold trim debate got louder after Astera Labs posted Q1 FY26 revenue of $308.4 million, up 93% year over year. That is a record quarter, and the stock now trades near 165x P/E at roughly $285.
The astera labs valuation reaction question is whether that multiple is defensible. AI connectivity stocks have rerated hard, and ALAB sits at the sharpest edge of that move.
Scorpio Switch Family and the AI Connectivity Story
Astera Labs sells silicon that moves data between GPUs, CPUs, and accelerators inside AI data centers. Scorpio is the product line that matters now, and the X Series is the ramp investors are pricing in.
Why scale-up switching matters
Scale-up switching connects GPUs inside a single AI training pod. Bandwidth here is the bottleneck for training the largest models, and hyperscalers will pay premium prices to remove it.
Where ALAB fits in the AI stack
The Scorpio X Series began shipping initial volumes in Q1 FY26, with the 320-lane SKU expected in Q2 FY26 and production ramping in H2 FY26. Management expects X Series to surpass P Series as the largest product line by year-end FY26.
NVIDIA sells the GPUs, Broadcom and Marvell sell custom ASICs, and Astera sells the connectivity glue tying it together, mapped in our AI infrastructure picks and shovels playbook.
Q1 FY26 Numbers: 93% YoY Revenue Growth
The Q1 FY26 print was strong on almost every line. Revenue hit $308.4 million, up 93% year over year and 14% sequentially, a record for the company.
What the gross margin tells us
GAAP gross margin came in at 76.3%, with non-GAAP gross margin at 76.4%, software-like profile on a hardware product line. Mid-70s margins say Astera is not competing on price; hyperscalers are paying for time-to-market and proven interoperability.
Sequential growth is the real tell
YoY growth at 93% looks dramatic, but the 14% sequential gain is the better signal because it shows the demand curve is still bending up.
Want exposure to the AI connectivity build-out without picking a single 165x P/E name? A basket across GPU, custom silicon, and connectivity spreads execution risk.
Verdict: Buy, Hold, or Trim ALAB at ~$285 Share Price
Here is the explicit call. At roughly $285 and ~165x P/E, ALAB is a Hold for existing positions, a Trim above $300, and a Wait for new buyers until a 20% pullback. Price is volatile, so treat $285 as a reference, not a precise entry.
Why Hold, not Sell
The Scorpio X-Series ramp into H2 FY26 is a genuine catalyst, and selling before that ramp prints means giving up the most concentrated piece of the thesis.
Why Trim above $300
At 165x P/E, every quarter has to be a beat-and-raise. One in-line print would compress the multiple sharply, and the stock has shown 15-20% drawdowns on softer guidance. Trimming 20-30% above $300 locks in gains and lets you redeploy on the next pullback.
Why wait for a 20% pullback to initiate
New buyers paying ~165x have almost no margin of safety; a 20% pullback brings the multiple closer to 130x, still rich but with more room for execution wobbles. Our NVIDIA vs TSMC vs Broadcom breakdown shows peers trading at far lower multiples on similar AI demand.
Customer Concentration: 5 Clients = 90% of Revenue
This is the risk the bulls underweight. Around five customers drive roughly 90% of Astera revenue, and those customers are major hyperscalers including AWS, Microsoft, Google, and Meta.
The two-way cut of concentration
That concentration cuts both ways. ALAB is winning at the deepest pockets in AI, but one customer pulling forward or pushing out orders can swing a full quarter materially.
The in-house silicon risk
Every hyperscaler is investing heavily in custom silicon, with Broadcom and Marvell as the named partners on most programs. If a hyperscaler brings connectivity in-house, even partially, the revenue impact on ALAB is immediate and material rather than spread across many smaller accounts.
How ALAB Compares with NVDA, AVGO, MRVL on Risk-Reward
The peer comp is where 165x looks hardest to defend. NVDA trades at a fraction of that multiple with diversified AI revenue across training, inference, networking, and software.
Broader silicon, lower multiples
AVGO and MRVL sit in the same AI silicon neighborhood with broader portfolios and more durable customer bases, and both trade at far lower multiples than ALAB on similar end-market exposure.
Growth is faster, but so is the risk
ALAB grows faster than any peer, which justifies a premium. The question is whether the premium should be 3x to 5x larger than the next grower at the same hyperscaler concentration, and that is where the math gets uncomfortable.
Conclusion
Astera Labs delivered a strong Q1 FY26 print, and the Scorpio X-Series ramp gives the bull case legs into H2 FY26. But 165x P/E leaves no room for wobbles, and 90% revenue concentration is a binary risk the valuation does not pad.
Hold what you own, trim above $300, and wait for a 20% pullback before initiating.
Ready to position your own AI connectivity exposure? Open a Gotrade account and start trading fractional shares of ALAB, NVDA, AVGO, and the rest of the AI infrastructure stack with as little as $1.
FAQ
Is ALAB a buy at $285 per share?
At 165x P/E, ALAB is a Hold for existing positions and a Wait for new buyers until at least a 20% pullback brings the multiple closer to peer ranges.
What did Astera Labs report in Q1 FY26?
Revenue of $308.4 million, up 93% YoY and 14% sequentially, with GAAP gross margin of 76.3% and non-GAAP gross margin of 76.4%.
How risky is Astera Labs customer concentration?
Around five hyperscaler customers drive roughly 90% of revenue, so a single customer pulling orders can swing an entire quarter materially.
How does ALAB compare with NVDA, AVGO, and MRVL?
ALAB grows faster but trades at a far higher P/E multiple, with narrower product breadth and heavier customer concentration than any of those three peers.
